All entries for: Xadcera Biopharmaceutical (Suzhou) Co. Ltd.

May 12, 2026

Xadcera Biopharmaceutical (Suzhou) Co. Ltd.

Investment: Designated

treatment of gastric cancer

Disease Area: Rare Diseases
Scroll to Top